Back To Index << Back To Terminology

# Value Set eHDSIVaccine 2022‑01‑31 15:00:00

This terminology is a snapshot as of 2026‑02‑11 10:48:51. Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id | 1.3.6.1.4.1.12559.11.10.1.3.1.42.28 | Effective Date | 2022‑01‑31 15:00:00 Other versions this id: eHDSIVaccine202602 - as of 2026‑02‑06 16:26:57 eHDSIVaccine202602 - as of 2026‑02‑06 16:19:05 eHDSIVaccine202602 - as of 2026‑02‑06 16:06:00 eHDSIVaccine202502 - as of 2025‑02‑17 15:33:02 eHDSIVaccine202401 - as of 2024‑01‑25 17:00:00 eHDSIVaccine202307 - as of 2023‑07‑05 13:45:00 eHDSIVaccine202301 - as of 2023‑01‑17 16:45:00 eHDSIVaccine202206 - as of 2022‑06‑23 16:00:00 eHDSIVaccine202104 - as of 2021‑04‑16 16:40:00 eHDSIVaccine202006 - as of 2020‑06‑17 11:49:20 eHDSIVaccine202004 - as of 2020‑04‑22 18:30:00 epSOSVaccine201711 - as of 2017‑11‑07 14:06:20 epSOSVaccineJuly 2009 - as of 2013‑06‑03
Status | Deprecated | Version Label | 202201
Name | eHDSIVaccine | Display Name | eHDSIVaccine
Description | The Value Set is used to identify the patient's vaccinations in the Patient Summary
Copyright | This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.
2 Source Code Systems | 2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC 2.16.840.1.113883.6.96 - SNOMED Clinical Terms - FHIR: http://snomed.info/sct - HL7 V2: SCT
Level/ Type | Code | Display Name | Code System
--- | --- | --- | ---
0‑L | 46233009 | Influenza virus vaccine (product) | SNOMED Clinical Terms
0‑L | 35736007 | Cholera vaccine | SNOMED Clinical Terms
0‑L | 421245007 | Diphtheria + pertussis + tetanus vaccine | SNOMED Clinical Terms
0‑L | 414004005 | Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine | SNOMED Clinical Terms
0‑L | 414005006 | Diphtheria + tetanus + pertussis + poliomyelitis vaccine | SNOMED Clinical Terms
0‑L | 350327004 | Diphtheria + tetanus vaccine | SNOMED Clinical Terms
0‑L | 428214002 | Diphtheria vaccine | SNOMED Clinical Terms
0‑L | 333680004 | Haemophilus influenzae Type b vaccine | SNOMED Clinical Terms
0‑L | 14745005 | Hepatitis A virus vaccine | SNOMED Clinical Terms
0‑L | 333702001 | Hepatitis A+B vaccine | SNOMED Clinical Terms
0‑L | 34689006 | Hepatitis B virus vaccine | SNOMED Clinical Terms
0‑L | 424519000 | Human papillomavirus vaccine | SNOMED Clinical Terms
0‑L | 427036009 | Influenza virus H5N1 vaccine | SNOMED Clinical Terms
0‑L | 333697005 | Japanese B encephalitis vaccine | SNOMED Clinical Terms
0‑L | 386012008 | Measles vaccine | SNOMED Clinical Terms
0‑L | 423531006 | Meningococcus vaccine | SNOMED Clinical Terms
0‑L | 90043005 | Mumps live virus vaccine | SNOMED Clinical Terms
0‑L | 61602008 | Pertussis vaccine | SNOMED Clinical Terms
0‑L | 333598008 | Pneumococcal vaccine | SNOMED Clinical Terms
0‑L | 111164008 | Poliovirus vaccine | SNOMED Clinical Terms
0‑L | 333606008 | Rabies vaccine | SNOMED Clinical Terms
0‑L | 116077000 | Rotavirus vaccine | SNOMED Clinical Terms
0‑L | 386013003 | Rubella vaccine | SNOMED Clinical Terms
0‑L | 33234009 | Smallpox vaccine | SNOMED Clinical Terms
0‑L | 333621002 | Tetanus vaccine | SNOMED Clinical Terms
0‑L | 333699008 | Tick-borne encephalitis vaccine | SNOMED Clinical Terms
0‑L | 420538001 | Tuberculosis vaccine | SNOMED Clinical Terms
0‑L | 89428009 | Typhoid vaccine | SNOMED Clinical Terms
0‑L | 56844000 | Yellow fever vaccine | SNOMED Clinical Terms
0‑L | 61153008 | Measles + Mumps + Rubella vaccine | SNOMED Clinical Terms
0‑L | 108729007 | Varicella vaccine | SNOMED Clinical Terms
0‑L | 1119305005 | SARS-CoV-2 antigen vaccine | SNOMED Clinical Terms
0‑L | 1119349007 | SARS-CoV-2 mRNA vaccine | SNOMED Clinical Terms
0‑L | 1157024006 | Inactivated whole SARS-CoV-2 antigen vaccine | SNOMED Clinical Terms
0‑L | 1162643001 | SARS-CoV-2 recombinant spike protein antigen vaccine | SNOMED Clinical Terms
0‑L | 28531000087107 | COVID-19 vaccine | SNOMED Clinical Terms
0‑L | 29061000087103 | COVID-19 non-replicating viral vector vaccine | SNOMED Clinical Terms
0‑L | J07AC | Anthrax vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AC01 | anthrax antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AD | Brucellosis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AD01 | brucella antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE | Cholera vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE01 | cholera, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE02 | cholera, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AF | Diphtheria vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AF01 | diphtheria toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG | Haemophilus influenzae B vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG01 | haemophilus influenzae B, purified antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG51 | haemophilus influenzae B, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH | Meningococcal vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH01 | meningococcus A, purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH02 | other meningococcal monovalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH05 | other meningococcal polyvalent purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH06 | meningococcus B, outer membrane vesicle vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH07 | meningococcus C, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH09 | meningococcus B, multicomponent vaccine | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AH10 | meningococcus A, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ | Pertussis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ01 | pertussis, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ02 | pertussis, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AJ52 | pertussis, purified antigen, combinations with toxoids | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AK | Plague vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AK01 | plague, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL | Pneumococcal vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL01 | pneumococcus, purified polysaccharides antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL02 | pneumococcus, purified polysaccharides antigen conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM | Tetanus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM01 | tetanus toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM51 | tetanus toxoid, combinations with diphtheria toxoid | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AN | Tuberculosis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AN01 | tuberculosis, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP | Typhoid vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP01 | typhoid, oral, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP02 | typhoid, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP03 | typhoid, purified polysaccharide antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AP10 | typhoid, combinations with paratyphi types | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AR | Typhus (exanthematicus) vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AR01 | typhus exanthematicus, inactivated, whole cell | WHO Anatomical Therapeutic Chemical classification
0‑L | J07AX | Other bacterial vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA | Encephalitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA01 | encephalitis, tick borne, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA02 | encephalitis, Japanese, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BA03 | encephalitis, Japanese, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB | Influenza vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB01 | influenza, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB02 | influenza, inactivated, split virus or surface antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB03 | influenza, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BB04 | influenza, virus like particles | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC | Hepatitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC01 | hepatitis B, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC02 | hepatitis A, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BC20 | combinations | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD | Measles vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD01 | measles, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD51 | measles, combinations with mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD52 | measles, combinations with mumps and rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD53 | measles, combinations with rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BE | Mumps vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BE01 | mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF | Poliomyelitis vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF01 | poliomyelitis oral, monovalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF02 | poliomyelitis oral, trivalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF03 | poliomyelitis, trivalent, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BF04 | poliomyelitis oral, bivalent, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BG | Rabies vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BG01 | rabies, inactivated, whole virus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH | Rota virus diarrhea vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH01 | rota virus, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BH02 | rota virus, pentavalent, live, reassorted | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ | Rubella vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ01 | rubella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BJ51 | rubella, combinations with mumps, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK | Varicella zoster vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK01 | varicella, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK02 | zoster, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BK03 | zoster, purified antigen | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BL | Yellow fever vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BL01 | yellow fever, live attenuated | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM | Papillomavirus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM01 | papillomavirus (human types 6, 11, 16, 18) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM02 | papillomavirus (human types 16, 18) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX | Other viral vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX01 | smallpox vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX02 | ebola vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX03 | covid-19 vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07BX04 | dengue virus vaccines | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA | Bacterial and viral vaccines, combined | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA01 | diphtheria-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA03 | diphtheria-rubella-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA04 | haemophilus influenzae B and poliomyelitis | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA05 | diphtheria-hepatitis B-pertussis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA07 | diphtheria-hepatitis B-tetanus | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA08 | haemophilus influenzae B and hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA10 | typhoid-hepatitis A | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | WHO Anatomical Therapeutic Chemical classification
0‑L | J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | WHO Anatomical Therapeutic Chemical classification
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
| XML JSON CSV SQL SVS FHIR (4.0) [xml / json]